1. Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry

   • C. Dive
   • P. Workman
   • J. V. Watson

   OriginalPaper Pages: 149 - 155

2. Protection against cisplatin nephrotoxicity by prochlorperazine

   • R. A. Kramer

   OriginalPaper Pages: 156 - 160

3. Influence of scheduling on two-drug combinations of alkylating agents in vivo

   • Beverly A. Teicher
   • Sylvia A. Holden
   • Terence S. Herman

   OriginalPaper Pages: 161 - 166

4. Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexate

   • Rakesh Goel
   • Raghuram Sanga
   • Stephen B. Howell

   OriginalPaper Pages: 167 - 172

5. Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors

   • K. Ferguson
   • D. Boschelli
   • S. S. Kerwar

   OriginalPaper Pages: 173 - 176

6. Comparative uptake and retention of adriamycin andN-benzyladriamycin-14-valerate in human CEM leukemic lymphocyte cell cultures

   • Mervyn Israel
   • Trevor W. Sweatman
   • Yoshihiro Koseki

   OriginalPaper Pages: 177 - 183

7. Isolation, identification and biological activity of a phyllanthoside metabolite produced in vitro by mouse plasma

   • Dennis E. Chapman
   • David J. Moore
   • Garth Powis

   OriginalPaper Pages: 184 - 188

8. 6-Ethylmercaptopurine-mediated growth inhibition of HL-60 cells in vitro irrespective of purine salvage

   • Diane S. Gibboney
   • Bernard T. French
   • Ronald W. Trewyn

   OriginalPaper Pages: 189 - 194

9. Validated HPLC procedures for the analysis of BMY-28090 in human plasma and urine

   • Robert C. Gaver
   • George Deeb
   • Alice M. George

   OriginalPaper Pages: 195 - 201

10. A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer

    • Egbert F. Smit
    • Henk H. Berendsen
    • Pieter E. Postmus

    OriginalPaper Pages: 202 - 204

11. Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233

    • G. Atassi
    • P. Dumont
    • P. Roger

    OriginalPaper Pages: 205 - 209

12. Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen

    • Claudia Ladner
    • Gerhard Ehninger
    • Michael R. Clemens

    OriginalPaper Pages: 210 - 212

13. Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation

    • Christopher Twelves
    • Robert Souhami
    • Anthony Goldstone

    OriginalPaper Pages: 213 - 218

14. A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer

    • J. Waxman
    • J. Sandow
    • G. Williams

    Short Communication Pages: 219 - 220

15. Reduction of B16 melanoma metastases by oral administration of egg-white lysozyme

    • Gianni Sava

    Short Communication Pages: 221 - 222

16. Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia

    • Eric Archimbaud
    • Jacques Troncy
    • Denis Fiere

    Short Communication Pages: 223 - 225

17. Meeting announcements

    Announcement Pages: 226 - 226